SCHEMBL10077111

SCHEMBL10077111

CC(C)OC(=O)CCC/C=C\C[C@@H]1C(N)[C@H](O)C[C@@H]1O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 3/20 0.63
PGR P06401 1/20 0.63
ADORA3 P0DMS8 1/20 0.63
ADRA2C P18825 1/20 0.63
SLC6A2 P23975 1/20 0.63
HTR2B P41595 1/20 0.63
MC3R P41968 1/20 0.63
SLC6A3 Q01959 1/20 0.63
SCN5A Q14524 1/20 0.63
PTGFR P43088 4/20 0.56
ABCB11 O95342 2/20 0.56
KDM4E B2RXH2 2/20 0.56
MEN1 O00255 1/20 0.56
MAPT P10636 1/20 0.56
MAPK1 P28482 1/20 0.56
KMT2A Q03164 1/20 0.56
CA2 P00918 4/20 0.52
TBXA2R P21731 3/20 0.52
ABCC4 O15439 1/20 0.47
ALDH1A1 P00352 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15473293 0.87 PDE4D (0.69) PDE4DPGRADORA3ADRA2CSLC6A2
SCHEMBL14968511 0.86 ALDH1A1 (0.56) PDE4DPGRADORA3ADRA2CSLC6A2
SCHEMBL16613944 0.83 PDE4D (0.61) PDE4DPGRADORA3ADRA2CSLC6A2
SCHEMBL8903202 0.82 PDE4D (0.78) PDE4DPGRADORA3ADRA2CSLC6A2
SCHEMBL8903200 0.82 PDE4D (0.78) PDE4DPGRADORA3ADRA2CSLC6A2
SCHEMBL8903428 0.81 PDE4D (0.84) PDE4DPGRADORA3ADRA2CSLC6A2
SCHEMBL8903423 0.81 PDE4D (0.84) PDE4DPGRADORA3ADRA2CSLC6A2
SCHEMBL18388401 0.81 PDE4D (0.84) PDE4DPGRADORA3ADRA2CSLC6A2
SCHEMBL7952226 0.81 PDE4D (0.58) PDE4DPGRADORA3ADRA2CSLC6A2
SCHEMBL7952228 0.81 PDE4D (0.58) PDE4DPGRADORA3ADRA2CSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012012282-A1 BIFUNCTIONAL RHO KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE INSPIRE PHARMACEUTICALS, INC. (US) 2012-01-26 WO disclosed